Drug comparisons
Dapagliflozin vs Acarbose
Compare Dapagliflozin (Farxiga) an SGLT2 inhibitor vs Acarbose (Precose) an alpha-glucosidase inhibitor for type 2 diabetes. Both oral, no black box.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting oral add-on therapy options for type 2 diabetes between SGLT2 and alpha-glucosidase inhibitors.
Bottom line
Dapagliflozin and Acarbose offer distinct oral mechanisms for type 2 diabetes control with neither universally superior.
All medication comparisons